Responding to the COVID-19 Pandemic: Improving Cancer Screening and Care in the United States
In March 2021, the American Cancer Society (ACS) created the ACS National Consortium to establish a collective national response to the detrimental impact of the COVID-19 pandemic on cancer screening and care. The consortium members included 28 government agencies, health organizations, national roundtables and cancer advocacy organizations, professional societies and associations, research institutions, and other relevant industry partners. The consortium members met to identify, discuss, and agree on consensus recommendations for improving cancer screening and care in the United States.
See the nine recommendations below or click on the button to download the full recommendations report.
Accelerate the collective action of partnerships, coalitions, and roundtables to influence the adoption of evidence-based cancer screening interventions and policies.
Accelerate a coordinated, innovative campaign to promote cancer screening as a public health priority.
Accelerate screening efforts by supporting and expanding proven programs that effectively reach communities that are historically excluded and underserved.
Accelerate the adoption of improved quality measures, accountability measures, and institutional goal-setting that prioritize equitable outcomes.
Accelerate innovations and interventions that better expand equitable access to cancer screening and care.
Strengthen trust in public health and health care systems by using a forward-looking, whole-person approach.
Comprehensive Preparedness Plans
Strengthen health system and community preparedness plans for health disruptions by including cancer and other chronic disease care in the plans.
Document and Understand Cancer Disparities
Strengthen the understanding of outcomes in cancer screening and care by collecting and utilizing demographic and social determinants of health data.
Strengthen transdisciplinary teamwork in support of health care delivery.